Buy ImmunoGen Stock | IMGN Stock Price & Latest News | Public
IMGN

ImmunoGen

$0.00 (0.00%)Today

    About IMGN

    ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded in March 1981 and is headquartered in Wa...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.06
    -0.12
    -0.18
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.17

    Actual EPS
    Q4 2020

    Stats

    Market Cap$916,34M
    Volume96,48k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$7.07
    1 Year Low$1.95
    Open$5.20
    High$5.40
    Low$5.20

    Buy any stock with any amount of money.

    Download the App
    Download the app